Interaction of activated Ras with Raf-1 alone may be sufficient for transformation of rat2 cells

被引:23
|
作者
Stang, S [1 ]
Bottorff, D [1 ]
Stone, JC [1 ]
机构
[1] UNIV ALBERTA, DEPT BIOCHEM, EDMONTON, AB T6G 2H7, CANADA
关键词
D O I
10.1128/MCB.17.6.3047
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
v-H-ras effector mutants have been assessed for transforming activity and for the ability of the encoded proteins to interact with Raf-1-, B-Raf-, byr2-, ralGDS-, and CDC25-encoded proteins in the yeast two-hybrid system. Transformation was assessed in rat2 cells as well as in a mutant cell line, rv68BUR, that affords a more sensitive transformation assay. Selected mutant Ras proteins were also examined for their ability to interact with an amino-terminal fragment of Raf-1 in vitro. Finally, possible cooperation between different v-H-ras effector mutants and between effector mutants and overexpressed Raf-1 was assessed. Ras transforming activity was shown to correlate best with the ability of the encoded protein to interact with Raf-1. No evidence for cooperation between v-H-ras effector mutants was found. Signaling through the Raf1-MEK-mitogen-activated protein kinase cascade may be the only effector pathway contributing to RAS transformation in these cells.
引用
收藏
页码:3047 / 3055
页数:9
相关论文
共 50 条
  • [31] Transformation of human hematopoietic cells by activated Raf oncoproteins: Abilities of A-Raf and Raf-1 to induce Mek-dependent autocrine growth factor synthesis and inhibit differentiation
    Steelman, LS
    Hoyle, PE
    WeinsteinOppenheimer, C
    Blalock, WL
    Cherwinski, H
    McMahon, M
    McCubrey, JA
    BLOOD, 1996, 88 (10) : 779 - 779
  • [32] Four human Ras homologs differ in their abilities to activate Raf-1, induce transformation, and stimulate cell motility
    Voice, JK
    Klemke, RL
    Le, A
    Jackson, JH
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (24) : 17164 - 17170
  • [33] The cytokine-activated tyrosine kinase JAK2 activates Raf-1 in a p21ras-dependent manner
    Xia, K.
    Mukhopadhyay, N. K.
    Inhorn, R. C.
    Barber, D. L.
    Proceedings of the National Academy of Sciences of the United States of America, 93 (21):
  • [34] The cytokine-activated tyrosine kinase JAK2 activates Raf-1 in a p21(ras)-dependent manner
    Xia, K
    Mukhopadhyay, NK
    Inhorn, RC
    Barber, DL
    Rose, PE
    Lee, RS
    Narsimhan, RP
    DAndrea, AD
    Griffin, JD
    Roberts, TM
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (21) : 11681 - 11686
  • [35] Wortmannin inhibits Ras and Raf-1 interaction induced by insulin in 3T3L1 adipocytes
    Suga, J
    Yoshimasa, Y
    Yamada, K
    Hayashi, T
    Yamamoto, Y
    Kosaki, A
    Kuzuya, H
    DIABETES, 1996, 45 : 436 - 436
  • [36] APOPTOSIS REGULATION BY INTERACTION OF BCL-2 PROTEIN AND RAF-1 KINASE
    WANG, HG
    MIYASHITA, T
    TAKAYAMA, S
    SATO, T
    TORIGOE, T
    KRAJEWSKI, S
    TANAKA, S
    HOVEY, L
    TROPPMAIR, J
    RAPP, UR
    REED, JC
    ONCOGENE, 1994, 9 (09) : 2751 - 2756
  • [37] Activation of the ras/raf-1 signal transduction pathway in carcinoid tumor cells results in morphologic transdifferentiation
    Sippel, RS
    Chen, H
    SURGERY, 2002, 132 (06) : 1035 - 1039
  • [38] Fusion of the binding domain of Raf-1 kinase with green fluorescent protein for activated Ras detection by fluorescence correlation spectroscopy
    Trier, U
    Olah, Z
    Kleuser, B
    Schäfer-Korting, M
    PHARMAZIE, 1999, 54 (04): : 263 - 268
  • [39] Oncogenic ras activation of Raf/mitogen-activated protein kinase-independent pathways is sufficient to cause tumorigenic transformation
    KhosraviFar, R
    White, MA
    Westwick, JK
    Solski, PA
    ChrzanowskaWodnicka, M
    vanAelst, L
    Wigler, MH
    Der, CJ
    MOLECULAR AND CELLULAR BIOLOGY, 1996, 16 (07) : 3923 - 3933
  • [40] Activated Raf-1 causes growth arrest in human small cell lung cancer cells
    Ravi, RK
    Weber, E
    McMahon, M
    Williams, JR
    Baylin, S
    Mal, A
    Harter, ML
    Dillehay, LE
    Claudio, PP
    Giordano, A
    Nelkin, BD
    Mabry, M
    JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (01): : 153 - 159